2020 SOHO Updates on IO for T-ALL/T-NHL: Is UCART7 Effective at Killing Cancer Cells? How Does NT-I7 Affect CAR-T in Vitro/in Vivo?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

2020 SOHO Updates on IO for T-ALL/T-NHL: Is UCART7 Effective at Killing Cancer Cells? How Does NT-I7 Affect CAR-T in Vitro/in Vivo?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING John DiPersio

0 views

October 30, 2020

SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘ resources and on-demand webinars, go to https://soho.click/register.
↖ read less

Comments 0

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve